Phase II study of gemcitabine plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-based chemotherapy

Conclusions: Gemcitabine plus S-1 offers a satisfactory clinical activity and an acceptable safety profile for recurrent and metastatic NPC patients after failure of platinum-based chemotherapy.

http://tam.sagepub.com/cgi/content/abstract/8/3/153?rss=1

Source: Therapeutic Advances in Medical Oncology - May 8, 2016 Category: Cancer & Oncology Authors: Peng, P., Ou, X., Liao, H., Liu, Y., Wang, S., Cheng, Z., Lin, Z. Tags: Original Research Source Type: research